Daudi

B lymphoblast cell line isolated from Burkitt's lymphoma patient; EBV positive

Cell Type:
Leukocyte (unspec.)
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
L A-020 1e6 51% 70% Plasmid (general) 2 µg 100 µl I/II/2b
SF CA-137 3e5 Plasmid (general) 20 µl 4D X-Unit

Citations

Categories:
Transfection, Cell Lines and Primary Cancer Cells 
Authors:
Gutierrez-Arcelus, M., Baglaenko, Y., Arora, J., Hannes, S., Luo, Y., Amariuta, T., Teslovich, N., Rao, D. A., Ermann, J., Jonsson, A. H., NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Navarrete, C., Rich, S. S., Taylor, K. D., Rotter, J. I., Gregersen, P. K., Esko, T., Brenner, M. B., & Raychaudhuri, S. 
In:
Nat Genet (2020) :  
Categories:
Transfection 
Authors:
Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y 
In:
J Immunol (2008) 181(3): 2010-8 
Categories:
Transfection 
Authors:
De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H, Giordano A, Leoncini L 
In:
Blood (2007) 110(4): 1301-7 
Categories:
Transfection 
Authors:
Simonson WT, Franco SJ, Huttenlocher A 
In:
J Immunol (2006) 177(11): 7707-14